Straube Richard 4
4 · SOLIGENIX, INC. · Filed Dec 11, 2020
Insider Transaction Report
Form 4
SOLIGENIX, INC.SNGX
Straube Richard
Sr VP & Chief Medical Officer
Transactions
- Award
Option (Right to Buy)
2020-12-10+40,000→ 40,000 totalExercise: $2.34From: 2020-12-10Exp: 2030-12-09→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The stock option vested immediately as to 10,000 shares and vests as to the remainder at a rate of 2,500 of the shares on each three (3) month anniversary of December 10,2020.